Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 104 entries
Sorted by: Best Match Show Resources per page
Designing a curriculum for the Internet-of-Things-Laboratory to foster creativity and a maker mindset within varying target groups

Asset based approaches STEM training

Lensing K.
GSID: wBXuJnNMLcgJ
K Lensing, J Friedhoff - Procedia Manufacturing, 2018 - Elsevier

… and the appropriate curricula in education and further training. Therefore, learning opportunities that … 4.0 and the lack of specialists respectively the acquisition of young talents for STEM. …

Cite
Lensing, K., & Friedhoff, J. (2018). Designing a curriculum for the Internet-of-Things-Laboratory to foster creativity and a maker mindset within varying target groups. Procedia Manufacturing, 23, 231-236.
Lensing, Karsten, and Joachim Friedhoff. "Designing a curriculum for the Internet-of-Things-Laboratory to foster creativity and a maker mindset within varying target groups." Procedia Manufacturing 23 (2018): 231-236.
Copy Download .nbib Format: MLA
Mortality in pediatric cardiac surgery. Review of a seven-year experience with 944 operations.

The Journal of the Kentucky Medical Association

Lansing AM, Girardet RE, Masri Z.
PMID: 6747446
J Ky Med Assoc. 1984 Jun;82(6):273-7.

No abstract available.

Cite
Lansing AM, Girardet RE, Masri Z. Mortality in pediatric cardiac surgery. Review of a seven-year experience with 944 operations. J Ky Med Assoc. 1984;82(6):273-7
Lansing, A. M., Girardet, R. E., & Masri, Z. (1984). Mortality in pediatric cardiac surgery. Review of a seven-year experience with 944 operations. The Journal of the Kentucky Medical Association, 82(6), 273-7.
Lansing, A M, et al. "Mortality in pediatric cardiac surgery. Review of a seven-year experience with 944 operations." The Journal of the Kentucky Medical Association vol. 82,6 (1984): 273-7.
Lansing AM, Girardet RE, Masri Z. Mortality in pediatric cardiac surgery. Review of a seven-year experience with 944 operations. J Ky Med Assoc. 1984 Jun;82(6):273-7. PMID: 6747446.
Copy Download .nbib Format: NLM
Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis.

JMM case reports

Meijer WJ, Linn FH, Wensing AM, Leavis HL, van Riel D, GeurtsvanKessel CH, Wattjes MP, Murk JL.
PMID: 28348797
JMM Case Rep. 2016 Dec 19;3(6):e005076. doi: 10.1099/jmmcr.0.005076. eCollection 2016 Dec.

No abstract available.

Cite
Meijer WJ, Linn FH, Wensing AM, et al. Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep. 2016;3(6):e005076doi: 10.1099/jmmcr.0.005076.
Meijer, W. J., Linn, F. H., Wensing, A. M., Leavis, H. L., van Riel, D., GeurtsvanKessel, C. H., Wattjes, M. P., & Murk, J. L. (2016). Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM case reports, 3(6), e005076. https://doi.org/10.1099/jmmcr.0.005076
Meijer, Wouter J, et al. "Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis." JMM case reports vol. 3,6 (2016): e005076. doi: https://doi.org/10.1099/jmmcr.0.005076
Meijer WJ, Linn FH, Wensing AM, Leavis HL, van Riel D, GeurtsvanKessel CH, Wattjes MP, Murk JL. Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep. 2016 Dec 19;3(6):e005076. doi: 10.1099/jmmcr.0.005076. eCollection 2016 Dec. PMID: 28348797; PMCID: PMC5343125.
Copy Download .nbib Format: NLM
Laryngeal actinomycosis.

Proceedings (Baylor University. Medical Center)

Lensing F, Abele T, Wiggins R, Quigley E.
PMID: 24381401
Proc (Bayl Univ Med Cent). 2014 Jan;27(1):35-6. doi: 10.1080/08998280.2014.11929047.

Actinomyces odontolyticus, a component of normal human flora, has been implicated in cervicofacial actinomycosis, which most commonly involves the perimandibular soft tissues and is characterized by slowly progressive abscess and sinus tract formation. Actinomycosis has rarely been reported to...

Cite
Lensing F, Abele T, Wiggins R, et al. Laryngeal actinomycosis. Proc (Bayl Univ Med Cent). 2014;27(1):35-6doi: 10.1080/08998280.2014.11929047.
Lensing, F., Abele, T., Wiggins, R., & Quigley, E. (2014). Laryngeal actinomycosis. Proceedings (Baylor University. Medical Center), 27(1), 35-6. https://doi.org/10.1080/08998280.2014.11929047
Lensing, Forrester, et al. "Laryngeal actinomycosis." Proceedings (Baylor University. Medical Center) vol. 27,1 (2014): 35-6. doi: https://doi.org/10.1080/08998280.2014.11929047
Lensing F, Abele T, Wiggins R, Quigley E. Laryngeal actinomycosis. Proc (Bayl Univ Med Cent). 2014 Jan;27(1):35-6. doi: 10.1080/08998280.2014.11929047. PMID: 24381401; PMCID: PMC3862130.
Copy Download .nbib Format: NLM
The differential diagnosis of congenital heart disease. II. Lesions with left-to-right shunt.

Canadian Medical Association journal

LANSING AM.
PMID: 14462224
Can Med Assoc J. 1961 Dec 23;85:1381-4.

No abstract available.

Cite
LANSING AM. The differential diagnosis of congenital heart disease. II. Lesions with left-to-right shunt. Can Med Assoc J. 1961;85:1381-4
LANSING, A. M. (1961). The differential diagnosis of congenital heart disease. II. Lesions with left-to-right shunt. Canadian Medical Association journal, 851381-4.
LANSING, A M. "The differential diagnosis of congenital heart disease. II. Lesions with left-to-right shunt." Canadian Medical Association journal vol. 85 (1961): 1381-4.
LANSING AM. The differential diagnosis of congenital heart disease. II. Lesions with left-to-right shunt. Can Med Assoc J. 1961 Dec 23;85:1381-4. PMID: 14462224; PMCID: PMC1848662.
Copy Download .nbib Format: NLM
[Constituents of Atractylis koreana].

Planta medica

Pachaly P, Lansing A, Sin KS.
PMID: 17262255
Planta Med. 1989 Feb;55(1):59-61. doi: 10.1055/s-2006-961826.

An investigation of the rhizomes of ATRACTYLIS KOREANA afforded, in addition to known selinane sesquiterpenoids, an ester of tetradeca-6, 12-diene-8, 10-diyne-1,3-diol and two isomers of 6-methyl-2-geranyl- P-benzoquinone, which are new compounds for the genus Atractylis. Their structures were established...

Cite
Pachaly P, Lansing A, Sin KS. Inhaltsstoffe von Atractylis koreana. [Constituents of Atractylis koreana]. Planta Med. 1989;55(1):59-61doi: 10.1055/s-2006-961826.
Pachaly, P., Lansing, A., & Sin, K. S. (1989). Inhaltsstoffe von Atractylis koreana. [Constituents of Atractylis koreana]. Planta medica, 55(1), 59-61. https://doi.org/10.1055/s-2006-961826
Pachaly, P, et al. "Inhaltsstoffe von Atractylis koreana." [Constituents of Atractylis koreana]. Planta medica vol. 55,1 (1989): 59-61. doi: https://doi.org/10.1055/s-2006-961826
Pachaly P, Lansing A, Sin KS. Inhaltsstoffe von Atractylis koreana. [Constituents of Atractylis koreana]. Planta Med. 1989 Feb;55(1):59-61. doi: 10.1055/s-2006-961826. German. PMID: 17262255.
Copy Download .nbib Format: NLM
Infective endocarditis: diagnosis, treatment, and mortality, as related to surgical timing and infectious organism.

Texas Heart Institute journal

Attum AA, Masri Z, Yared SF, Johnson GS, Girardet R, Lansing AM.
PMID: 15227297
Tex Heart Inst J. 1987 Dec;14(4):401-10.

To evaluate the timing of surgical treatment in infective endocarditis and to determine the relationship between the risk of mortality and the species of infectious organism, we reviewed a consecutive series of 65 cases involving patients with infective endocarditis...

Cite
Attum AA, Masri Z, Yared SF, et al. Infective endocarditis: diagnosis, treatment, and mortality, as related to surgical timing and infectious organism. Tex Heart Inst J. 1987;14(4):401-10
Attum, A. A., Masri, Z., Yared, S. F., Johnson, G. S., Girardet, R., & Lansing, A. M. (1987). Infective endocarditis: diagnosis, treatment, and mortality, as related to surgical timing and infectious organism. Texas Heart Institute journal, 14(4), 401-10.
Attum, A A, et al. "Infective endocarditis: diagnosis, treatment, and mortality, as related to surgical timing and infectious organism." Texas Heart Institute journal vol. 14,4 (1987): 401-10.
Attum AA, Masri Z, Yared SF, Johnson GS, Girardet R, Lansing AM. Infective endocarditis: diagnosis, treatment, and mortality, as related to surgical timing and infectious organism. Tex Heart Inst J. 1987 Dec;14(4):401-10. PMID: 15227297; PMCID: PMC324765.
Copy Download .nbib Format: NLM
Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease.

The American journal of pathology

Blumenthal HT, Lansing AI, Wheeler PA.
PMID: 19970771
Am J Pathol. 1944 Jul;20(4):665-87.

No abstract available.

Cite
Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease. Am J Pathol. 1944;20(4):665-87
Blumenthal, H. T., Lansing, A. I., & Wheeler, P. A. (1944). Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease. The American journal of pathology, 20(4), 665-87.
Blumenthal, H T, et al. "Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease." The American journal of pathology vol. 20,4 (1944): 665-87.
Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease. Am J Pathol. 1944 Jul;20(4):665-87. PMID: 19970771; PMCID: PMC2033157.
Copy Download .nbib Format: NLM
Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism.

Thrombosis journal

Prins MH, Lensing AW.
PMID: 23829521
Thromb J. 2013 Jul 06;11(1):13. doi: 10.1186/1477-9560-11-13.

BACKGROUND: Direct oral anticoagulants that target a single coagulation factor have been developed as an alternative to standard therapies with heparin and/or vitamin K antagonists. The purpose of this study was to derive non-inferiority margins suitable for randomised clinical...

Cite
Prins MH, Lensing AW. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thromb J. 2013;11(1):13doi: 10.1186/1477-9560-11-13.
Prins, M. H., & Lensing, A. W. (2013). Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thrombosis journal, 11(1), 13. https://doi.org/10.1186/1477-9560-11-13
Prins, Martin H, and Lensing, Anthonie Wa. "Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism." Thrombosis journal vol. 11,1 (2013): 13. doi: https://doi.org/10.1186/1477-9560-11-13
Prins MH, Lensing AW. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thromb J. 2013 Jul 06;11(1):13. doi: 10.1186/1477-9560-11-13. PMID: 23829521; PMCID: PMC3710481.
Copy Download .nbib Format: NLM
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

Thrombosis journal

Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS.
PMID: 24053656
Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21.

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring...

Cite
Prins MH, Lensing AW, Bauersachs R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013;11(1):21doi: 10.1186/1477-9560-11-21.
Prins, M. H., Lensing, A. W., Bauersachs, R., van Bellen, B., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., Raskob, G. E., Berkowitz, S. D., Wells, P. S. (2013). Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis journal, 11(1), 21. https://doi.org/10.1186/1477-9560-11-21
Prins, Martin H, et al. "Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies." Thrombosis journal vol. 11,1 (2013): 21. doi: https://doi.org/10.1186/1477-9560-11-21
Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21. PMID: 24053656; PMCID: PMC3850944.
Copy Download .nbib Format: NLM
PTSD and comorbid AUD: a review of pharmacological and alternative treatment options.

Substance abuse and rehabilitation

Ralevski E, Olivera-Figueroa LA, Petrakis I.
PMID: 24648794
Subst Abuse Rehabil. 2014 Mar 07;5:25-36. doi: 10.2147/SAR.S37399. eCollection 2014.

BACKGROUND: Although posttraumatic stress disorder (PTSD) and alcohol use disorders (AUD) frequently co-occur there are no specific treatments for individuals diagnosed with these comorbid conditions. The main objectives of this paper are to review the literature on pharmacological options...

Cite
Ralevski E, Olivera-Figueroa LA, Petrakis I. PTSD and comorbid AUD: a review of pharmacological and alternative treatment options. Subst Abuse Rehabil. 2014;5:25-36doi: 10.2147/SAR.S37399.
Ralevski, E., Olivera-Figueroa, L. A., & Petrakis, I. (2014). PTSD and comorbid AUD: a review of pharmacological and alternative treatment options. Substance abuse and rehabilitation, 525-36. https://doi.org/10.2147/SAR.S37399
Ralevski, Elizabeth, et al. "PTSD and comorbid AUD: a review of pharmacological and alternative treatment options." Substance abuse and rehabilitation vol. 5 (2014): 25-36. doi: https://doi.org/10.2147/SAR.S37399
Ralevski E, Olivera-Figueroa LA, Petrakis I. PTSD and comorbid AUD: a review of pharmacological and alternative treatment options. Subst Abuse Rehabil. 2014 Mar 07;5:25-36. doi: 10.2147/SAR.S37399. eCollection 2014. PMID: 24648794; PMCID: PMC3953034.
Copy Download .nbib Format: NLM
Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir.

Case reports in infectious diseases

Meijer WJ, Kromdijk W, van den Broek MP, Haas PJ, Minnema MC, Boucher CA, de Lange DW, Wensing AM.
PMID: 26346659
Case Rep Infect Dis. 2015;2015:504975. doi: 10.1155/2015/504975. Epub 2015 Aug 09.

Immunocompromised patients are at increased risk of complications of influenza virus infection. We report on two critically ill patients on immunosuppressive medication with influenza pneumonia. In both patients, oseltamivir monotherapy did not result in clearance of the virus after...

Cite
Meijer WJ, Kromdijk W, van den Broek MP, et al. Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Case Rep Infect Dis. 2015;2015:504975doi: 10.1155/2015/504975.
Meijer, W. J., Kromdijk, W., van den Broek, M. P., Haas, P. J., Minnema, M. C., Boucher, C. A., de Lange, D. W., & Wensing, A. M. (2015). Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Case reports in infectious diseases, 2015504975. https://doi.org/10.1155/2015/504975
Meijer, Wouter J, et al. "Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir." Case reports in infectious diseases vol. 2015 (2015): 504975. doi: https://doi.org/10.1155/2015/504975
Meijer WJ, Kromdijk W, van den Broek MP, Haas PJ, Minnema MC, Boucher CA, de Lange DW, Wensing AM. Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Case Rep Infect Dis. 2015;2015:504975. doi: 10.1155/2015/504975. Epub 2015 Aug 09. PMID: 26346659; PMCID: PMC4546743.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 104 entries